MGMT and neoplasm: This study adds to the current knowledge base by including a large number of patients with a rare tumor, patients with higher grade tumors, patients treated previously with chemotherapy, everolimus and sunitinib, as well as the reporting of MGMT expression where tissue was available for analysis.